Hitting a therapeutic sweet spot with Optimer®
Dr Daniel Wiseman is a Senior Clinical Lecturer at the University of Manchester, and a Consultant Haematologist at the Christie NHS Foundation. He is exploring Optimer® binders as a novel therapeutic strategy for the treatment of leukemia.
Here he explains the advantages this modality has brought to his research and his experience of working with the technology.